Renagel tablets — Cigna
control or reduction of serum phosphorus in patients with chronic kidney disease (CKD) on dialysis or end stage renal disease (ESRD)
Preferred products
- generic lanthanum carbonate chewable tablets
- Phoslyra oral solution
- generic sevelamer carbonate powder for oral suspension
- generic sevelamer carbonate tablets
- generic sevelamer hydrochloride tablets
- Velphoro chewable tablets
Initial criteria
- If the patient has tried one Step 1 Product, approve a Step 2 Product
Approval duration
1 year